Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST Trials. - Fulcher, Greg; Mehta, Roopa; Fita, Edmond G.; Ekelund, Magnus; Bain, Stephen C. (Diabetes Therapy, 2019)